Get the Stockscreener App
284.55
0.90%
2.5682
Overview
News
Price History
Option Chain
Financials
Why CI Down?
Discussions
Forecast
Stock Split
Dividend History
Cigna Group stock is traded at $284.55, with a volume of 501.70K.
It is up +0.90% in the last 24 hours and down -1.72% over the past month.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
See More
Previous Close:
$281.98
Open:
$286.53
24h Volume:
501.70K
Relative Volume:
0.32
Market Cap:
$75.24B
Revenue:
$278.13B
Net Income/Loss:
$6.74B
P/E Ratio:
12.05
EPS:
23.6047
Net Cash Flow:
$7.66B
1W Performance:
+3.20%
1M Performance:
-1.72%
6M Performance:
+1.93%
1Y Performance:
-9.28%
1-Day Range:
$284.34
$289.91
1-Week Range:
$273.66
$289.91
52-Week Range:
$239.51
$315.47
Cigna Group Stock (CI) Company Profile
Name
Cigna Group
Sector
Industry
Phone
(860) 226-6000
Address
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Compare CI vs UNH, CVS, ELV, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
284.44 | 74.59B | 278.13B | 6.74B | 7.66B | 23.60 |
UNH
Unitedhealth Group Inc
|
425.48 | 379.60B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
103.37 | 130.25B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
417.40 | 88.64B | 200.42B | 5.24B | 6.45B | 23.50 |
HUM
Humana Inc
|
395.46 | 47.17B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cigna Group Stock (CI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-26 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-14-25 | Initiated | Goldman | Buy |
| Feb-06-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Feb-05-24 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-05-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-01-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-04-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-11-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| Jun-06-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Neutral |
| Apr-05-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-03-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Nov-21-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Jul-14-22 | Downgrade | Jefferies | Buy → Hold |
| Jun-22-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Hold |
| May-27-22 | Resumed | Bernstein | Mkt Perform |
| May-26-22 | Upgrade | BofA Securities | Underperform → Neutral |
| May-16-22 | Upgrade | JP Morgan | Neutral → Overweight |
| May-09-22 | Upgrade | Cowen | Market Perform → Outperform |
| Feb-07-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-21-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-17-21 | Initiated | Seaport Research Partners | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Mkt Perform |
| Sep-10-21 | Downgrade | BofA Securities | Buy → Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-06-21 | Reiterated | BofA Securities | Buy |
| Aug-06-21 | Reiterated | Citigroup | Buy |
| Aug-06-21 | Reiterated | Deutsche Bank | Buy |
| Aug-06-21 | Reiterated | Jefferies | Buy |
| Aug-06-21 | Reiterated | Mizuho | Buy |
| Aug-06-21 | Reiterated | Oppenheimer | Outperform |
| Aug-06-21 | Reiterated | Truist | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-04-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-24-20 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-11-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Aug-06-19 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Apr-23-19 | Initiated | UBS | Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-24-18 | Initiated | Edward Jones | Buy |
| Mar-13-18 | Initiated | Bernstein | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Overweight |
| Jan-03-18 | Initiated | Goldman | Neutral |
| Nov-03-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-22-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-12-17 | Initiated | Credit Suisse | Outperform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-08-17 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
View All
Cigna Group Stock (CI) Latest News
Specialty Pharmacy Gets Even Hotter After Cigna Investment And Peak Rock’s Asembia Buy - Forbes
The Cigna Group sets July 30 earnings call, webcast and replay - Stock Titan
Cigna Group focuses on health benefits and steady operations - AD HOC NEWS
Cigna Group (CI) Could Be 17% Undervalued On Its $100 Million Evernorth AI Push - simplywall.st
The Cigna Group highlights its health services model as investors track long-term growth potential - AD HOC NEWS
UnitedHealth Bets on Profitability Over Growth: Will It Pay Off? - TradingView
Cigna Group outlines its role in US health coverage and benefits - AD HOC NEWS
What Cigna Group (CI)'s US$100 Million Pharmacy Forward AI Bet Means For Shareholders - Yahoo Finance
New Cigna CEO’s patient-first focus to face Wall Street test - Crain's New York Business
Top Cigna Group (CI) Competitors 2026 - MarketBeat
Cigna's Evernorth division announces $100M specialty drug AI program - BenefitsPRO
Evernorth Invests $100M for AI Specialty Pharmacy Program - MedCity News
Evernorth Launches AI-Driven Specialty Care Initiative Backed by $100M Investment - citybiz
Cigna Group outlines growth strategy as health benefits demand evolves - AD HOC NEWS
Cigna (CI) Unveils $100M AI-Driven Specialty Care Program to Enh - GuruFocus
Cigna’s Evernorth Makes $100 Million AI Specialty Pharmacy Investment - Forbes
Cigna launches AI-enabled specialty care program with a $100M investment - Seeking Alpha
Cigna invests $100 million in new AI-powered specialty pharmacy program - Reuters
Cigna’s CEO vows to put patients first. Wall Street is watching - Modern Healthcare
New Cigna CEO’s Patient-First Focus to Face Wall Street Test - Bloomberg.com
New Cigna CEO’s Patient-First Focus to Face Wall Street Test (1) - Bloomberg Law News
Evernorth unveils new AI-powered specialty pharmacy program, Pharmacy Forward - Fierce Healthcare
The Evernorth Behavioral Health Program from Cigna Groupa quiet revenue engine in mental health c - AD HOC NEWS
AIDS Group Says Cigna-Owned Express Scripts Hurts Patients - Law360
Cigna, Others Fight Ohio AG's Drug Price-Fixing Suit - Law360
The Cigna Group (CI) Has a Health-Services Engine Bigger Than the Insurer Label - AlphaStreet
Cigna, UC Health extend contract as coverage negotiations continue - Sacramento Bee
Cigna Group stock underperforms Tuesday when compared to competitors - MarketWatch
Cigna and Community Medical Centers in contract dispute - ABC30 Fresno
Cigna Group outlines CEO transition as shares trade below recent highs - AD HOC NEWS
Cigna Group CEO transition and guidance lift, shares react ahead of July change - AD HOC NEWS
Cigna’s Removal From Russell Growth and Defensive Indices Might Change The Case For Investing In Cigna Group (CI) - simplywall.st
2 Healthcare Stocks for Long-Term Investors and 1 We Turn Down - The Globe and Mail
The Cigna Group(NYSE: CI) dropped from Russell 1000 Growth-Defensive Index - marketscreener.com
How payers, drugmakers can collaborate to drive value-based care - Fierce Healthcare
Cigna Group stock outperforms competitors despite losses on the day - MarketWatch
The Cigna Group(NYSE: CI) dropped from Russell 1000 Defensive Index - marketscreener.com
Advocare, Cigna reach last-minute deal keeping 900 doctors in-network - The Business Journals
The Cigna Group(NYSE: CI) dropped from Russell 3000E Growth Benchmark - marketscreener.com
The Cigna Group(NYSE: CI) dropped from Russell 1000 Growth Benchmark - marketscreener.com
Evernorth Virtual Care from Cigna Groupalways-on doctor access for US members - AD HOC NEWS
The Cigna Group(NYSE: CI) dropped from Russell 1000 Value-Defensive Index - marketscreener.com
Cigna Group highlights health strategy, shares backed by steady S&P 500 role - AD HOC NEWS
The Cigna Dental 1500 plan from Cigna Groupclear annual cap for everyday care - AD HOC NEWS
Cigna (CI) Launches 10 Year Veteran Grants And $3 Million Youth Mental Health Push - simplywall.st
Cigna Group holds a marked sector position, shares trade in a tight Nasdaq range - Ad-hoc-news.de
Cigna Medicare Advantage plans from Cigna Group2026 benefits sharpen primary care focus - AD HOC NEWS
Enterprise value to revenue forward of The Cigna Group – NYSE:CI - TradingView
Following weeks of buildup, Cigna and UC Health agree on contract renewal - The Business Journals
Cigna Group earnings outlook in focus, shares tracked on the NYSE - Ad-hoc-news.de
Enterprise value to EBIT forward of The Cigna Group – NYSE:CI - TradingView
Cigna Group Stock (CI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cigna Group Stock (CI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Kates Jamie G | Chief Accounting Officer |
Jun 12 '26 |
Sale |
298.61 |
899 |
268,452 |
2,368 |
2.28%
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):